PL2766424T3 - Synteza wielofazowego żelu do wstrzyknięć zawierającego wolny i usieciowany jednofazowy kwas hialuronowy i dwufazowy kwas hialuronowy w połączeniu z hydroksyapatytem, z mikrokapsułkowanym inhibitorem hialuronidazy - Google Patents

Synteza wielofazowego żelu do wstrzyknięć zawierającego wolny i usieciowany jednofazowy kwas hialuronowy i dwufazowy kwas hialuronowy w połączeniu z hydroksyapatytem, z mikrokapsułkowanym inhibitorem hialuronidazy

Info

Publication number
PL2766424T3
PL2766424T3 PL12772232T PL12772232T PL2766424T3 PL 2766424 T3 PL2766424 T3 PL 2766424T3 PL 12772232 T PL12772232 T PL 12772232T PL 12772232 T PL12772232 T PL 12772232T PL 2766424 T3 PL2766424 T3 PL 2766424T3
Authority
PL
Poland
Prior art keywords
hyaluronic acid
microencapsulated
hydroxyapatite
injectable
synthesis
Prior art date
Application number
PL12772232T
Other languages
English (en)
Inventor
Marco Zazzetta
Original Assignee
Regenyal Laboratories S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenyal Laboratories S.R.L. filed Critical Regenyal Laboratories S.R.L.
Publication of PL2766424T3 publication Critical patent/PL2766424T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/01—Use of inorganic substances as compounding ingredients characterized by their specific function
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/32—Phosphorus-containing compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL12772232T 2011-10-12 2012-10-05 Synteza wielofazowego żelu do wstrzyknięć zawierającego wolny i usieciowany jednofazowy kwas hialuronowy i dwufazowy kwas hialuronowy w połączeniu z hydroksyapatytem, z mikrokapsułkowanym inhibitorem hialuronidazy PL2766424T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000138A ITAN20110138A1 (it) 2011-10-12 2011-10-12 Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
PCT/EP2012/004215 WO2013053457A1 (en) 2011-10-12 2012-10-05 Synthesis of an injectable multiphasic gel containing free and cross-linked monophasic hyaluronic acid and biphasic hyaluronic acid combined with hydroxyapatite with microencapsulated hyaluronidase inhibitor.
EP12772232.0A EP2766424B1 (en) 2011-10-12 2012-10-05 Synthesis of an injectable multiphasic gel containing free and cross-linked monophasic hyaluronic acid and biphasic hyaluronic acid combined with hydroxyapatite with microencapsulated hyaluronidase inhibitor.

Publications (1)

Publication Number Publication Date
PL2766424T3 true PL2766424T3 (pl) 2017-12-29

Family

ID=44993641

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12772232T PL2766424T3 (pl) 2011-10-12 2012-10-05 Synteza wielofazowego żelu do wstrzyknięć zawierającego wolny i usieciowany jednofazowy kwas hialuronowy i dwufazowy kwas hialuronowy w połączeniu z hydroksyapatytem, z mikrokapsułkowanym inhibitorem hialuronidazy

Country Status (5)

Country Link
EP (1) EP2766424B1 (pl)
ES (1) ES2642680T3 (pl)
IT (1) ITAN20110138A1 (pl)
PL (1) PL2766424T3 (pl)
WO (1) WO2013053457A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014056722A2 (fr) * 2012-10-08 2014-04-17 Anteis S.A. Formulation aqueuse stérile injectable à base d'acide hyaluronique réticulé et d'hydroxyapatite pour usage esthétique
US20150238525A1 (en) * 2012-10-08 2015-08-27 Aptissen S.A. Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and on hydroxyapatite, for therapeutic use
KR101720426B1 (ko) * 2015-09-01 2017-04-14 (주)시지바이오 히알루론산 조성물 및 그의 제조방법
CN110087701A (zh) 2016-07-27 2019-08-02 马贝尔斯莱德斯有限公司 交联透明质酸和羟基磷灰石的线
CA3035153A1 (en) * 2016-09-07 2018-03-15 Luminera Derm Ltd. Injectable gels comprising cross-linked hyaluronic acid and hydroxyapatite, and methods of manufacturing thereof
EP3946246A4 (en) * 2019-03-24 2023-06-21 Allergan Pharmaceuticals International Limited INJECTABLE HOMOGENEOUS JELLS WITH SEVERAL FORMS OF HYALURONIC ACID AND PROCESS FOR THEIR PREPARATION

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
ITPD20030286A1 (it) * 2003-11-27 2005-05-28 Fidia Advanced Biopolymers Srl Strutture composite multistrato contenenti acido ialuronico
FR2865737B1 (fr) 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
BRPI0515191A (pt) * 2004-08-13 2008-07-08 Angiotech Internac Ag composição farmacêutica, método para aumentar osso ou substituir perda óssea, método para reduzir a dor associada com cicatriz pós-cirúrgica, método para prevenir aderência cirúrgicas, método para aumento ou reparo de pele ou tecido, método para manter volume em fluido ocular durante cirurgia ocular, método para reduzir a dor associada com osteoartrite, método para tratar doença de refluxo gastroesofágico, método para tratar ou prevenir incontinência urinária, método para tratar ou prevenir incontinência fecal, implante método e dispositivo médico
US20070184087A1 (en) 2006-02-06 2007-08-09 Bioform Medical, Inc. Polysaccharide compositions for use in tissue augmentation
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use

Also Published As

Publication number Publication date
WO2013053457A1 (en) 2013-04-18
ITAN20110138A1 (it) 2012-01-11
ES2642680T3 (es) 2017-11-17
EP2766424A1 (en) 2014-08-20
EP2766424B1 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
IL276643A (en) Methods to increase the transfer of drugs and the effectiveness of therapeutic agents
PL2766424T3 (pl) Synteza wielofazowego żelu do wstrzyknięć zawierającego wolny i usieciowany jednofazowy kwas hialuronowy i dwufazowy kwas hialuronowy w połączeniu z hydroksyapatytem, z mikrokapsułkowanym inhibitorem hialuronidazy
HK1208350A1 (en) Sterilised composition comprising at least one hyaluronic acid and magnesium ascorbyl phosphate
HUE051612T2 (hu) Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
HUE056793T2 (hu) Injektálható hialuronsav-gél
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
HK1258973A1 (zh) 作為細胞因子活性調節劑的硫酸化的透明質酸
IL225245A0 (en) Gel compound
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
HRP20150117T1 (en) Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen
HK1176055A1 (zh) 活動的調製器及其調製方法
EP2566368A4 (en) UNIVERSAL STORAGE AND SHELVING SYSTEM
HK1204998A1 (en) Combinations of histone deacetylase inhibitor and pazopanib and uses thereof
HK1210941A1 (en) Modified hyaluronic acid derivatives and use thereof
GB201302656D0 (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
EP2636666A4 (en) TRANS-2 DECENTRIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEREOF
EP2640257A4 (en) EFFECTIVE SHIELDING AND REFRACTION TARGETS
EP2596366A4 (en) COMBINATION THERAPY WITH MDM2 AND EFGR INHIBITORS
ZA201302638B (en) Methods of treating eye diseases associated with inflammation and vascular proliferation
EP2579872A4 (en) HAMMER OF ACT ACTIVITY
EP2569004A4 (en) LACTOFERRIN-BASED BIOMATERIALS FOR TISSUE REGENERATION AND MEDICATION DELIVERY
ZA201304369B (en) Use of glycosaminoglycan lipote esters in the trichology field
EP2568992A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AN ALGUE APPROPRIATE FOR INCREASING THE EFFICACY OF AN ENZYMATIC INHIBITOR
AU335567S (en) Combination patient education and storage article